ConductScience.org, home

Paper3134490

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess.

Wood CA and 8 others. J Infect Dis, 1988. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. Papers, record 3134490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3134490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess.
PubMed
Journal
J Infect Dis
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
4.92
iCite
Revised in PubMed
2019-05-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wood CAC A
2Norton DRD R
3Kohlhepp SJS J
4Kohnen PWP W
5Porter GAG A
6Houghton DCD C
7Brummett RER E
8Bennett WMW M
9Gilbert DND N

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AbscessMajor topic
Hair Cells, AuditoryMajor topic
Kidney DiseasesMajor topic
Pseudomonas InfectionsMajor topic
TobramycinMajor topic
Animals
DNA Replication
Drug Administration Schedule
Inflammation
Inulin
Kidney
Pseudomonas aeruginosa
Rats
Rats, Inbred F344

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
41646972Synergy between immune system and antibiotics drives infection control in mice.Front Immunol2025https://conductscience.org/library/papers/41646972PubMed
34907595Therapeutic evaluation of immunomodulators in reducing surgical wound infection.FASEB J2022https://conductscience.org/library/papers/34907595PubMed
31475156Ultra-High-Precision, in-vivo Pharmacokinetic Measurements Highlight the Need for and a Route Toward More Highly Personalized Medicine.Front Mol Biosci2019https://conductscience.org/library/papers/31475156PubMed
18852271Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/18852271PubMed
10803457A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosides.Clin Pharmacokinet2000https://conductscience.org/library/papers/10803457PubMed
10390201Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10390201PubMed
8950834Pharmacokinetics and dosing regimen of aminosidine in the dog.Vet Res Commun1996https://conductscience.org/library/papers/8950834PubMed
8787901Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8787901PubMed
8719234Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.J Pharmacokinet Biopharm1995https://conductscience.org/library/papers/8719234PubMed
8681976Once-daily dosing of aminoglycosides.Eur J Clin Microbiol Infect Dis1995https://conductscience.org/library/papers/8681976PubMed
8611830Single or multiple daily doses of aminoglycosides: a meta-analysis.BMJ1996https://conductscience.org/library/papers/8611830PubMed
8540723Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8540723PubMed
8239615Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239615PubMed
8203864Fever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokinetics.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8203864PubMed
8119044Aminoglycoside dosage regimens. Is once a day enough?Clin Pharmacokinet1993https://conductscience.org/library/papers/8119044PubMed
8067780Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067780PubMed
8067732Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067732PubMed
7955770What is the evidence for once-daily aminoglycoside therapy?Clin Pharmacokinet1994https://conductscience.org/library/papers/7955770PubMed
7851055Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.Clin Pharmacokinet1994https://conductscience.org/library/papers/7851055PubMed
2665645Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2665645PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3134490

GET https://conductscience.org/api/papers/v1/3134490/cited_by?page=2